Q 32 Bio Inc (QTTB)

Finanzdaten der Q 32 Bio Inc-Aktie (QTTB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	18.08%9.12	7.72	7.86	7.58	9.17
Research and Development	32.35%4.26	3.22	3.32	3.56	5.16
Operating Income/Loss	18.08%-9.12	-7.72	45.88	-7.58	-9.17
Net Interest Income/Expense	28.12%-0.25	-0.19	1.93	-0.22	-0.28
Nonoperating Income/Loss	52.21%0.17	0.11	11.85	0.19	-0.32
Income Tax Expense/Benefit	-	-	-	-	-
	17.57%-8.95	-7.61	57.73	-7.39	-9.49
Attributable To Parent	17.57%-8.95	-7.61	57.73	-7.39	-9.49
Available To Common Stockholders, Basic	17.57%-8.95	-7.61	27.94	-7.39	-9.49
Basic Average Shares	44.32%20.34	14.10	0.09	12.24	12.20
Diluted Average Shares	44.32%20.34	14.10	0.10	12.24	12.20
Basic Earnings Per Share	18.52%-0.44	-0.54	4.71	-0.60	-0.78
Diluted Earnings Per Share	18.52%-0.44	-0.54	4.71	-0.60	-0.78